Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1885 4
1886 3
1887 3
1888 1
1898 1
1900 1
1904 4
1905 1
1928 1
1952 1
1981 1
1983 2
1986 2
1987 2
1988 1
1989 1
1991 1
1992 1
1993 2
1994 2
1995 3
1997 1
1998 3
1999 4
2000 5
2001 4
2002 7
2003 6
2004 5
2005 12
2006 12
2007 18
2008 29
2009 28
2010 23
2011 22
2012 34
2013 50
2014 61
2015 71
2016 58
2017 58
2018 84
2019 97
2020 151
2021 156
2022 184
2023 64
Text availability
Article attribute
Article type
Publication date

Search Results

1,157 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Austegaard
Page 1
Did you mean austegard e[au] (2 results)?
A single-cell survey of cellular hierarchy in acute myeloid leukemia.
Wu J, Xiao Y, Sun J, Sun H, Chen H, Zhu Y, Fu H, Yu C, E W, Lai S, Ma L, Li J, Fei L, Jiang M, Wang J, Ye F, Wang R, Zhou Z, Zhang G, Zhang T, Ding Q, Wang Z, Hao S, Liu L, Zheng W, He J, Huang W, Wang Y, Xie J, Li T, Cheng T, Han X, Huang H, Guo G. Wu J, et al. Among authors: e w. J Hematol Oncol. 2020 Sep 25;13(1):128. doi: 10.1186/s13045-020-00941-y. J Hematol Oncol. 2020. PMID: 32977829 Free PMC article.
Trismus therapy devices: A systematic review.
E C, M D, K C, V A, P M, C F, Jr D, Jr C. E C, et al. Oral Oncol. 2022 Mar;126:105728. doi: 10.1016/j.oraloncology.2022.105728. Epub 2022 Jan 29. Oral Oncol. 2022. PMID: 35104753 Review.
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, Yu J, Bu Z, Chen L, Du Y, Wang X, Wu A, Li G, Su X, Xiao G, Cui M, Wu D, Chen L, Wu X, Zhou Y, Zhang L, Dang C, He Y, Zhang Z, Sun Y, Li Y, Chen H, Bai Y, Qi C, Yu P, Zhu G, Suo J, Jia B, Li L, Huang C, Li F, Ye Y, Xu H, Wang X, Yuan Y, E JY, Ying X, Yao C, Shen L, Ji J; RESOLVE study group. Zhang X, et al. Among authors: e jy. Lancet Oncol. 2021 Aug;22(8):1081-1092. doi: 10.1016/S1470-2045(21)00297-7. Epub 2021 Jul 9. Lancet Oncol. 2021. PMID: 34252374 Clinical Trial.
Deep learning of cross-species single-cell landscapes identifies conserved regulatory programs underlying cell types.
Li J, Wang J, Zhang P, Wang R, Mei Y, Sun Z, Fei L, Jiang M, Ma L, E W, Chen H, Wang X, Fu Y, Wu H, Liu D, Wang X, Li J, Guo Q, Liao Y, Yu C, Jia D, Wu J, He S, Liu H, Ma J, Lei K, Chen J, Han X, Guo G. Li J, et al. Among authors: e w. Nat Genet. 2022 Nov;54(11):1711-1720. doi: 10.1038/s41588-022-01197-7. Epub 2022 Oct 13. Nat Genet. 2022. PMID: 36229673
Long COVID occurrence in COVID-19 survivors.
Sugiyama A, Miwata K, Kitahara Y, Okimoto M, Abe K, E B, Ouoba S, Akita T, Tanimine N, Ohdan H, Kubo T, Nagasawa A, Nakanishi T, Takafuta T, Tanaka J. Sugiyama A, et al. Among authors: e b. Sci Rep. 2022 Apr 11;12(1):6039. doi: 10.1038/s41598-022-10051-z. Sci Rep. 2022. PMID: 35411017 Free PMC article.
1,157 results